Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Emesis and anti-emesis

R J Naylor1, J A Rudd

  • 1School of Pharmacy, Bradford, West Yorkshire.

Cancer Surveys
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

The 5-HT3 receptor antagonists, like ondansetron, are crucial for managing chemotherapy-induced nausea and vomiting. These drugs target specific receptors in the gut and brain, improving cancer patient quality of life.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coventry and Warwickshire Hospital Laundry.

The Hospital·2018
Same author

Collector or Secretary?

The Hospital·2018
Same author

Suspected acorn toxicity in nine horses.

Equine veterinary journal·2014
Same author

Comparison of flunixin meglumine and meloxicam for post operative management of horses with strangulating small intestinal lesions.

Equine veterinary journal·2013
Same author

Blood lactate concentrations in ponies and miniature horses with gastrointestinal disease.

Equine veterinary journal·2013
Same author

Evaluation of cardiac phenotype in horses with type 1 polysaccharide storage myopathy.

Journal of veterinary internal medicine·2012
Same journal

Future directions: bladder cancer.

Cancer surveys·2004
Same journal

Radiotherapy and chemotherapy for invasive bladder cancer.

Cancer surveys·2004
Same journal

The role of surgery in the multimodality treatment of bladder cancer.

Cancer surveys·2004
Same journal

Clonal development of bladder cancer and its relevance to the clinical potential of HLA antigen and TP53 based gene therapy.

Cancer surveys·2004
Same journal

Clinical evaluation of immunotherapy: are there differences between papillary and flat in situ bladder cancer?

Cancer surveys·2004
Same journal

Molecular biological changes in bladder cancer.

Cancer surveys·2004
See all related articles

Area of Science:

  • Neuroscience
  • Pharmacology
  • Gastroenterology

Background:

  • Chemotherapy and radiotherapy often induce nausea and vomiting (emesis).
  • The precise mechanisms of emesis and anti-emetic drug action require further elucidation.
  • 5-HT3 receptors are implicated in the emetic reflex.

Purpose of the Study:

  • To hypothesize the role of 5-HT3 receptors in chemotherapy-induced emesis.
  • To identify 5-HT3 receptors as the primary sites of action for ondansetron and related anti-emetic agents.
  • To explore the impact of 5-HT3 receptor antagonists on emesis research and cancer patient treatment.

Main Methods:

  • Review and consideration of existing evidence on emesis mechanisms.
  • Hypothesizing the involvement of 5-HT3 receptors in the gut and brainstem (AP/NTS).

Related Experiment Videos

  • Analysis of the therapeutic effects of ondansetron and 5-HT3 receptor antagonists.

    • Main Results:

    • 5-HT3 receptors are hypothesized to be pivotal in mediating chemotherapy and radiotherapy-induced emesis.
    • Ondansetron and related agents act on these 5-HT3 receptors to produce anti-emetic effects.
    • 5-HT3 receptor antagonists have significantly improved emesis management in cancer patients and revitalized emesis research.

    Conclusions:

    • 5-HT3 receptor antagonists have redefined understanding of chemotherapy-induced emesis phases and neurotransmitter links.
    • Further research into emetic mechanisms may identify new targets for broad-spectrum anti-emetic agents.
    • Improved anti-emetic therapies enhance cancer patient quality of life and treatment outcomes.